Table 1 Characteristics of the sustained period of “getting to zero” VAP prevention program in the ICU
2009 | 2010 | |
|---|---|---|
Patient-days (total) | 10,889 | 11,095 |
Number of patients | 2,705 | 2,717 |
Age, mean ± SD (in years) | 67±19 | 66±18 |
Male, n (%) | 1,571 (58.1%) | 1,587 (58.4%) |
APACHE, mean ± SD | 18±6 | 18±7 |
Ventilator-days (total) | 3,009 | 3,043 |
Ventilator utilization ratio | 0.28 | 0.27 |
MV days – median (IQR) | 4 (1–22) | 3.7 (1–23) |
Ventilator-free days | 7,880 | 8,052 |
ICU LOS days – mean ± SD | 3.9±0.4 | 4.0±0.3 |
Compliance with process measures, n (%) | ||
HOB observations | 2362/2396 (98.6%) | 2260/2486 (90.9%) |
Daily “sedation interruptions” | 2358/2396 (98.4%) | 2273/2486 (91.4%) |
Gastric prophylaxis | 2393/2396 (99.9%) | 2276/2486 (91.5%) |
DVT/PE prevention | 2363/2396 (98.6%) | 2266/2486 (91.1%) |
Ventilator circuits without changes | 610/611 (99.8%) | 387/390 (99.2%) |
HMEs changed | 584/611 (95.5%) | 368/390 (94.3%) |
Ventilator-circuit-tubing condensate | 564/611 (92.3%) | 360/390 (92.3%) |
CASS endotracheal tube - n | 342 | 311 |
Number of VAPs | 4 | 6 |
Number of VATs | 3 | 6 |
VAP rate per 1,000 ventilator-days | 1.3 | 2.0 |
VAT rate per 1,000 ventilator-days | 1.0 | 2.0 |
In-hospital mortality in VAP patients, n (%) | 4/4 (100) | 5/6 (83) |
In-hospital mortality in ICU patients, n | 196 | 220 |
In-hospital mortality in ICU patients per 10,000 patient days | 180 | 198 |